Published on
18:30 GMT
Hormone Replacement Therapy Guidelines for Survivors of BRCA-Mutated Triple-Negative Breast Cancer
Premenopausal women with a BRCA1 or BRCA2 mutation have a greater lifetime risk for ovarian cancer and are often advised to undergo risk-reducing bilateral salpingo-oophorectomy (BSO). This procedure can initiate premature menopause because it leads to …
Source:
Physician's Weekly
-
Neutral
